# A Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIP Study)

> **NCT03362632** · — · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 400 (estimated)

## Conditions studied

- End Stage Liver Disease
- Infection
- Spontaneous Bacterial Peritonitis

## Interventions

- **DRUG:** Antibiotics

## Key facts

- **NCT ID:** NCT03362632
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-06-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2018-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03362632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03362632, "A Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIP Study)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03362632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*